NASDAQ · PEPG
PepGen Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PEPG: Nov 11, 2026
PepGen Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.27. The reported EPS for the same quarter last year was $-0.52.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.27 | $-0.26 | $-0.29 | 5 |
| Dec 2026 | $-0.32 | $-0.21 | $-0.53 | 4 |
| Mar 2027 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Jun 2027 | $-0.22 | $-0.22 | $-0.22 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews · NASDAQ.com- Zacks · May 20, 9:35 AM EDTPepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerPepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Zacks · May 13, 12:00 PM EDTPepGen (PEPG) Upgraded to Buy: Here's What You Should KnowPepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Fintel · Feb 25, 3:03 PM ESTOppenheimer Initiates Coverage of PepGen (PEPG) with Outperform RecommendationFintel reports that on February 25, 2026, Oppenheimer initiated coverage of PepGen (NasdaqGS:PEPG) with a Outperform recommendation. Analyst Price Forecast Suggests 64.08% Upside
- Zacks · Dec 10, 9:55 AM ESTHow Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44%The mean of analysts' price targets for PepGen (PEPG) points to a 75.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- Zacks · Nov 25, 1:08 PM ESTSarepta's Stock Rises on Positive Updates on DM1 TherapySRPT's stock jumps as its SRP-1003 study advances with a positive safety review and new dosing cohorts underway.
- Fintel · Nov 16, 9:52 PM ESTPepGen (PEPG) Price Target Increased by 17.65% to 10.20The average one-year price target for PepGen (NasdaqGS:PEPG) has been revised to $10.20 / share. This is an increase of 17.65% from the prior estimate of $8.67 dated November 7, 2025. The price target is an average of many targets provided by analysts. The lat
- Fintel · Nov 13, 7:05 PM ESTHC Wainwright & Co. Maintains PepGen (PEPG) Buy RecommendationFintel reports that on November 13, 2025, HC Wainwright & Co. maintained coverage of PepGen (NasdaqGS:PEPG) with a Buy recommendation. Analyst Price Forecast Suggests 76.94% Upside
- RTTNews · Oct 1, 12:17 AM EDTBiotech Stocks Rebound After Hours Amid Broader Sector Tailwinds(RTTNews) – Biotech stocks posted strong after-hours gains Tuesday, with several small-cap names rebounding despite limited news flow. Broader sentiment may have been supported by Pfizer's announcement of U.S. drug price cuts and a $70 billion investment in domestic manufacturing
- Fintel · Sep 30, 8:05 PM EDTWedbush Maintains PepGen (PEPG) Outperform RecommendationFintel reports that on September 30, 2025, Wedbush maintained coverage of PepGen (NasdaqGS:PEPG) with a Outperform recommendation. Analyst Price Forecast Suggests 84.78% Upside
- Fintel · Sep 30, 8:23 AM EDTPepGen (PEPG) Price Target Increased by 21.95% to 8.50The average one-year price target for PepGen (NasdaqGS:PEPG) has been revised to $8.50 / share. This is an increase of 21.95% from the prior estimate of $6.97 dated September 10, 2025. The price target is an average of many targets provided by analysts. The la
- Fintel · Sep 25, 8:06 PM EDTStifel Maintains PepGen (PEPG) Buy RecommendationFintel reports that on September 25, 2025, Stifel maintained coverage of PepGen (NasdaqGS:PEPG) with a Buy recommendation. Analyst Price Forecast Suggests 19.66% Upside
- NASDAQ.com · Sep 25, 8:29 AM EDTPre-Market Most Active for Sep 25, 2025 : PEPG, LAC, TSLL, OPEN, RIG, INTC, CIFR, IONZ, OKLO, BBAI, BB, QBTSThe NASDAQ 100 Pre-Market Indicator is down -179.9 to 24,323.67. The total Pre-Market volume is currently 256,184,714 shares traded.The following are the most active stocks for the pre-market session: PepGen Inc. (PEPG) is +3.9706 at $6.63, with 48,564,958 shares traded. As repo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for PepGen Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.